title: Octreotide in pediatric patients.
authors.affiliation: Department of Pediatrics, Marshfield Clinic, Marshfield, Wisconsin 54449, USA. heikenen.janice@marshfieldclinic.org
authors.forename: Janice B
authors.initials: JB
authors.lastname: Heikenen
authors.forename: John F
authors.initials: JF
authors.lastname: Pohl
authors.forename: Steven L
authors.initials: SL
authors.lastname: Werlin
authors.forename: John C
authors.initials: JC
authors.lastname: Bucuvalas
mesh_terms: D000930:Antidiarrheals / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D002648:Child; D003967:Diarrhea / Q000188:drug therapy; D005765:Gastrointestinal Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy; D005769:Gastrointestinal Motility / Q000187:drug effects; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy; D006801:Humans; D015282:Octreotide / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D010195:Pancreatitis / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000930:Antidiarrheals; D018931:Antineoplastic Agents, Hormonal; D005765:Gastrointestinal Agents; D015282:Octreotide